A Phase I/II Study of MM-111 in Combination with Herceptin
K
Kathy Miller, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to determine the safety of MM-111 and Herceptin
Description
The purpose of this study is to determine the safety of MM-111 and Herceptin
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Breast Cancer
-
Age: Between 18 Years - 100 Years
-
Gender: All
Updated on
20 Nov 2022.
Study ID: 1105005405